As part of our ongoing research we have developed a new anti-inflammatory nanotherapy based on the ternary supramolecular assembly of poly-β-amino-cyclodextrin (PolyCD) and hyaluronic acid (HA) loaded with the non-steroidal anti-inflammatory drug diclofenac (DCF). Our goal is to obtain biodegradable, biocompatible and non-immunogenic nanosystems constructed with polymeric cyclodextrins that combine the properties of biomaterials.
Supramolecular assemblies based on Polymeric Cyclodextrin, Hyaluronic acid and Diclofenac as anti inflammatory nanodrug
Burduja N.;Mazzaglia A
2022
Abstract
As part of our ongoing research we have developed a new anti-inflammatory nanotherapy based on the ternary supramolecular assembly of poly-β-amino-cyclodextrin (PolyCD) and hyaluronic acid (HA) loaded with the non-steroidal anti-inflammatory drug diclofenac (DCF). Our goal is to obtain biodegradable, biocompatible and non-immunogenic nanosystems constructed with polymeric cyclodextrins that combine the properties of biomaterials.File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
2022_SCICASI_Reggio Calabria_O29_Burduja et al.pdf
non disponibili
Tipologia:
Abstract
Licenza:
Nessuna licenza dichiarata (non attribuibile a prodotti successivi al 2023)
Dimensione
1.34 MB
Formato
Adobe PDF
|
1.34 MB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
